NCT06457789 Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer Status RECRUITING Phase NA
NCT06448910 Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06431685 Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer Status RECRUITING Phase PHASE1
NCT06424821 Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC Status RECRUITING Phase PHASE2
NCT06422143 Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] Status RECRUITING Phase PHASE3
NCT06414915 Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation Status NOT_YET_RECRUITING Phase PHASE2
NCT06403436 A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06400160 Clinical Trial of TB511 in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06362980 A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations Status RECRUITING Phase PHASE1
NCT06362369 A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy Status RECRUITING Phase PHASE1/PHASE2
NCT06361927 A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients Status RECRUITING Phase PHASE2
NCT06343402 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT06339242 A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis Status RECRUITING Phase PHASE2
NCT06332300 An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC Status WITHDRAWN Phase PHASE2
NCT06332287 A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis Status RECRUITING Phase PHASE2
NCT06329648 Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06328049 A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC Status RECRUITING Phase PHASE2
NCT06326411 A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors Status RECRUITING Phase PHASE1
NCT06317558 Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy Status RECRUITING Phase N/A
NCT06317324 Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With Interlobular Fissure Invasion. Status RECRUITING Phase N/A